Yamamoto Y, Koma H, Nishii S, Yagami T. Anti-Neuron-Specific Enolase Antibody Induced Neuronal Cell Death in a Novel Fashion. Mol Neurobiol. 2020 Jan 31.
Yamamoto Y, Koma H, Yagami T. 15-deoxy-Δ12, 14-prostaglandin J2 inhibits cell migration on renal cell carcinoma via down-regulation of focal adhesion kinase signaling. Biol Pharm Bull. 2020; 43: 153-157.
Koma H, Yamamoto Y, Kumagai H, Yagami T. 4,4-Diisothiocyanatostilbene Disulfonic Acid Enhanced 15-Deoxy-Δ12,14-prostaglandin J2-Induced Neuronal Apoptosis. Biol Pharm Bull. 2019;42(11):1913-1920. doi: 10.1248/bpb.b19-00536.
Koma H, Yamamoto Y, Fujita T, Yagami T. 15-deoxy-Δ12, 14-prostaglandin J2 enhances anticancer activities independently of VHL status in renal cell carcinomas. Biochem. Biophys. Rep. 2019; Volume 18, July, 100608-100608.
Yamamoto Y, Koma H, Ayaka Nishi, Yagami T. Anti-heat shock 70 kDa protein antibody induced neuronal cell death. Biol. Pharm. Bull. 2017; 40: 402–412.
Yamamoto Y, Yamamoto T, Koma H, Nishii A, Yagami T. Synergistic effects of 15-deoxy Δ12,14-prostaglandin J2 on the anti-tumor activity of doxorubicin in renal cell carcinoma. Biochem. Biophys. Rep. 2017; 9:61-66.
Koma H, Yamamoto Y, Nishii A, Yagami T. 15-Deoxy-Δ12,14-prostaglandin J2 induced neurotoxicity via suppressing phosphoinositide 3-kinase. Neuropharmacology. 2016 Oct 19;113(Pt A):416-425.
Yamamoto Y, Koma H, Yagami T. A plausible involvement of plasmalemmal voltage-dependent anion channel in the neurotoxicity of 15-deoxy-Δ 12;14-prostaglandin J2. The 18th World Congress of Basic and Clinical Pharmacology. July 1-6, 2018 (Kyoto, Japan)
Fujita T, Asanoma Y, Shirai W, Hashimoto E, Echigo T, Yoneda Y, Kumagai H, Yamamoto Y, Koma H, Yagami T. Synergistic effects of 15-deoxy-Δ12,14-prostaglandin J2 and anticancer agents on renal cell carcinomas. The 18th World Congress of Basic and Clinical Pharmacology. July 1-6, 2018 (Kyoto, Japan)